In a report released today, Brian Tanquilut from Jefferies maintained a Buy rating on HCA Healthcare Inc (NYSE: HCA), with a price target of $158. The company’s shares opened today at $134.87, close to its 52-week high of $141.11.
According to TipRanks.com, Tanquilut is a 4-star analyst with an average return of 5.6% and a 54.8% success rate. Tanquilut covers the Services sector, focusing on stocks such as Addus Homecare Corp, US Physical Therapy, and Acadia Healthcare.
Currently, the analyst consensus on HCA Healthcare Inc is a Strong Buy with an average price target of $150.08, representing an 11.3% upside. In a report released yesterday, Cantor Fitzgerald also reiterated a Buy rating on the stock with a $150 price target.
.
See today’s analyst top recommended stocks >>
HCA Healthcare Inc’s market cap is currently $46.89B and has a P/E ratio of 17.03. The company has a Price to Book ratio of -7.83.
Based on the recent corporate insider activity of 125 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
HCA Healthcare, Inc. is a health care services company, which engages in operating hospitals, freestanding surgery centers and emergency rooms, and urgent care centers. It offers a full range of services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services. The company was founded on November 22, 2010 and is headquartered in Nashville, TN.
